Eagle Bay Advisors LLC Atai Life Sciences N.V. Transaction History

Eagle Bay Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 19, 2022	BUY	$3.03 - $5.32 $3,938 - $6,916	1,300 New	1,300 $4.73 Million
Q1 2022 May 11, 2022	SELL	$4.66 - $7.66 $6,058 - $9,958	-1,300 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$6.82 - $17.8 $8,866 - $23,140	-1,300 Reduced 50.0%	1,300 $10,000
Q3 2021 Nov 12, 2021	BUY	$13.62 - $19.48 $35,412 - $50,648	2,600 New	2,600 $38,000

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Eagle Bay Advisors LLC with notifications on news.